Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects

Neurobiology of novelty seeking

(2021) Zahra Z. Farahbakhsh et al.   SCIENCE

Antidepressant-like effects of URB597 and JZL184 in male and female rats exposed to early life stress

(2020) Shirley Alteba et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice

(2019) Marta Kruk-Slomka et al.   MOLECULAR NEUROBIOLOGY

Endocannabinoid Signaling Mediates Local Dendritic Coordination between Excitatory and Inhibitory Synapses

(2019) Hai Yin Hu et al.   Cell Reports

Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD

(2018) Sharon Fidelman et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective

(2018) Julia M. Sheffield et al.   NEUROPSYCHOLOGY REVIEW

Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses

(2018) Tina Zimmermann et al.   NEUROPSYCHOPHARMACOLOGY

The current conceptualization of negative symptoms in schizophrenia

(2017) Stephen R. Marder et al.   World Psychiatry

Sex differences in hippocampal response to endocannabinoids after exposure to severe stress

(2016) Tomer Mizrachi Zer-Aviv et al.   HIPPOCAMPUS

Orchestrated activation of mGluR5 and CB1 promotes neuroprotection

(2016) Edleusa M. L. Batista et al.   Molecular Brain

Sex Differences in Molecular Signaling at Inhibitory Synapses in the Hippocampus

(2015) N. Tabatadze et al.   JOURNAL OF NEUROSCIENCE

Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders

(2015) S A Barnes et al.   MOLECULAR PSYCHIATRY

A systematic review of the antipsychotic properties of cannabidiol in humans

(2015) Tabitha A. Iseger et al.   SCHIZOPHRENIA RESEARCH

The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia

(2014) Lakshmi Rajagopal et al.   CURRENT PHARMACEUTICAL DESIGN

Prereproductive Stress to Female Rats Alters Corticotropin Releasing Factor Type 1 Expression in Ova and Behavior and Brain Corticotropin Releasing Factor Type 1 Expression in Offspring

(2013) Hiba Zaidan et al.   BIOLOGICAL PSYCHIATRY

Phencyclidine-Induced Social Withdrawal Results from Deficient Stimulation of Cannabinoid CB1 Receptors: Implications for Schizophrenia

(2013) Alexandre Seillier et al.   NEUROPSYCHOPHARMACOLOGY

Endocannabinoids in Amygdala and Nucleus Accumbens Mediate Social Play Reward in Adolescent Rats

(2012) V. Trezza et al.   JOURNAL OF NEUROSCIENCE

Sex differences in cannabinoid pharmacology: A reflection of differences in the endocannabinoid system?

(2012) Rebecca M. Craft et al.   LIFE SCIENCES

Insights into the regulation of protein abundance from proteomic and transcriptomic analyses

(2012) Christine Vogel et al.   NATURE REVIEWS GENETICS

Evidence for involvement of nitric oxide and GABAB receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex

(2012) Nicole L. Roenker et al.   NEUROPHARMACOLOGY

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia

(2011) David A. Lewis et al.   TRENDS IN NEUROSCIENCES

Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors

(2010) MS García-Gutiérrez et al.   BRITISH JOURNAL OF PHARMACOLOGY

Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats

(2010) Ji-Tao Li et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Rethinking schizophrenia

(2010) Thomas R. Insel   NATURE

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism

(2010) Joanna C. Neill et al.   PHARMACOLOGY & THERAPEUTICS

Signaling pathways in schizophrenia: emerging targets and therapeutic strategies

(2010) Caline S. Karam et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat

(2009) Claire E. McKibben et al.   BEHAVIOURAL BRAIN RESEARCH

Brief exposure to methamphetamine (METH) and phencyclidine (PCP) during late development leads to long-term learning deficits in rats

(2009) Ilsun M. White et al.   BRAIN RESEARCH

Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats

(2009) Agnieszka Nikiforuk et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Role of cannabis and endocannabinoids in the genesis of schizophrenia

(2009) Emilio Fernandez-Espejo et al.   PSYCHOPHARMACOLOGY

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

(2008) Věra Bubeníková-Valešová et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia

(2008) G. Gonzalez-Burgos et al.   SCHIZOPHRENIA BULLETIN